MOEを使用した論文の一覧です。研究の参考にご利用下さい。 （現在弊社で把握しているものであり、MOEを使用した論文の全てを掲載しているわけではありません。 論文を出版された方、一覧に掲載されていない論文をご存知の方は、こちらまでお知らせいただけましたら幸いです。）

• MOEを使用した論文
• 弊社製MOEアドオンプログラムASEDockを使用した論文 (ASEDock)

1. Amari, S.; Aizawa, M.; Zhang, J.; Fukuzawa, K.; Mochizuki, Y.; Iwasawa, Y.; Nakata, K.; Chuman, H.; Nakano, T.
   VISCANA: Visualized Cluster Analysis of Protein-Ligand Interaction Based on the ab Initio Fragment Molecular Orbital Method for Virtual Ligand Screening,
   J. Chem. Inf. Model., 2006, 46, 221-230.
   
   
2. Arakawa, M.; Hasegawa, K.; Funatsu, K.
   Tailored scoring function of Trypsin-benzamidine complex using COMBINE descriptors and support vector regression,
   Chemom. Intell. Lab. Syst., 2008, 92, 145-151.
   
   
3. Auzanneau, F.-I.; Sourial, E.; Schmidt, J.M.; Feher, M.
   Stochastic conformational search on the Lewis X (Le^x) trisaccharide and three Le^x analogues,
   Can. J. Chem., 2002, 80, 1088-1095.
   
   
4. Azuma, M.; Kabe, Y.; Kuramori, C.; Kondo, M.; Yamaguchi, Y.;, Handa, H.
   Adenine Nucleotide Translocator Transports Haem Precursors into Mitochondria,
   PLoS ONE, 2008, 3, e3070.
   
   
5. Bajorath, J.
   Selected concepts and investigations in compound classification, molecular descriptor analysis, and virtual screening.
   J. Chem. Inf. Comput. Sci., 2001, 41, 233-245.
   
   
6. Baraldi, P.G.; Cacciari, B.; Moro, S.; Spalluto, G.; Pastorin, G.; Da Ros, T.; Klotz, K.-N.; Varani, K.; Gessi, S.; Borea, P. A.
   Synthesis, biological activity, and molecular modeling investigation of new pyrazolo[4,3-e]-1,2,4-triazolo[1,5-c]pyrimidine derivatives as human A(3) adenosine receptor antagonists,
   J. Med. Chem., 2002, 45, 770-780.
   
   
7. Baraldi, P.G.; Cacciari, B.; Romagnoli, R.; Spalluto, G.; Moro, S.; Klotz, K.-N.; Leung, E.; Varani, K.; Gessi, S.; Merighi, S.; Borea, P.A.
   Pyrazolo [4,3-e]-1,2,4-triazolo[1,5-c]pyrimidine derivatives as highly potent and selection human A(3) adenosine receptor antagonists: Influence of the chain at the N(8) pyrazole nitrogen,
   J. Med. Chem., 2000, 43, 4768-4780.
   
   
8. Baudry, J.; Li, W.; Pan, L.; Berenbaum, M.R.; Schuler, M.A..
   Molecular docking of substrates and inhibitors in the catalytic site of CYP6B1, an insect cytochrome P450 monooxygenase, Protein Eng., 2003, 16, 577-587.
   
   
9. Baurin, N.; Mozziconacci JC.; Arnoult, E.; Chavatte, P; Marot, C.; Morin-Allory, L..
   2D QSAR Consensus Prediction for High-Throughput Virtual Screening. An Application to COX-2 Inhibition Modeling and Screening of the NCI Database, J. Chem. Inf. Comput. Sci., 2004, 44, 276-285.
   
   
10. Cen, X.; Nitta, A.: Ohya, S.; Zhao, Y.; Ozawa, N.;, Mouri, A.; Ibi, D.; Wang, L.; Suzuki, M.; Saito, K.; Ito, Y.; Kawagoe, T.; Noda, Y.; Ito, Y.; Furukawa, S.; Nabeshima, T..
    An Analog of a Dipeptide-Like Structure of FK506 Increases Glial Cell Line-Derived Neurotrophic Factor Expression through cAMP Response Element-Binding Protein Activated by Heat Shock Protein 90/Akt Signaling Pathway, J. Neurosci., 2006, 26, 3335-3344.
    
    
11. Chen. R.; Yokoyama, M.; Sato, H.; Reilly, C.; Mansky, L.M..
    Human Immunodeficiency Virus Mutagenesis during Antiviral Therapy: Impact of Drug-Resistant Reverse Transcriptase and Nucleoside and Nonnucleoside Reverse Transcriptase Inhibitors on Human Immunodefiency Virus Type 1 Mutation Frequencies, J. Virol., 2005, 79, 12045-12057.
    
    
12. Chou. K.-C.; Howe, W.J.
    Prediction of the tertiary structure of the beta-secretase zymogen. Biochemical and Biophysical Research Communications, 2002, 292, 702-708.
    
    
13. Daines, R.A.; Pendrak, I.; Sham, K.; Van Aller, G.S.; Konstantinidis, A.K.; Lonsdale, J.T.; Janson, C.A.; Qiu, X.; Brandt, M.; Khandekar, S.S.; Silverman, C.; Head, M.S.
    First x-ray cocrystal structure of a bacterial FabH condensing enzyme and a small molecule inhibitor achieved using rational design and homology modeling. J. Med. Chem., 2003, 46, 5-8.
    
    
14. Demura, M.; Yoshida, T.; Hirokawa, T.; Kumaki, Y.; Aizawa, T.; Nitta, K.; Bitter, I.; Toth ,K..
    Interaction of dopamine and acetylcholine with an amphiphilic resorcinarene receptor in aqueous micelle system, Bioorg. Med. Chem. Lett., 2005, 15, 1367-1370.
    
    
15. Duffy, K.J.; Shaw, A.N.; Delorme, E.; Dillon, S.B.; Erickson-Miller, C.; Giampa, L.; Huang, Y.; Keenan, R.M.; Lamb, P.; Liu, N.; Miller, S.G.; Price, A.T.; Rosen, J.; Smith, H.; Wiggall, K.J.; Zhang, L.; Luengo, J.I.
    Identification of a pharmacophore for thrombopoietic activity of small, non-peptidyl molecules. 1. Discovery and optimization of salicylaldehyde thiosemicarbazone thrombopoietin mimics, J. Med. Chem., 2002, 45, 3573-3575.
    
    
16. Duffy, K.J.; Price, A.T.; Delorme, E.; Dillon, S.B.; Duquenne, C.; Erickson-Miller, C.; Giampa, L.; Huang, Y.; Keenan, R.M.; Lamb, P.; Liu, N.; Miller, S.G.; Rosen, J.; Shaw, A.N.; Smith, H.; Wiggall, K.J.; Zhang, L.; Luengo, J.I.
    Identification of a pharmacophore for thrombopoietic activity of small, non-peptidyl molecules. 2. Rational design of naphtho[1,2-d] imidazole thrombopoietin mimics, J. Med. Chem., 2002, 45, 3576-3578.
    
    
17. Ermondi, G.; Caron, G.; Lawrence, R.; Longo, D.
    Docking studies on NSAID/COX-2 isozyme complexes using Contact Statistics analysis.
    J. Comput. Aided. Mol. Des., 2004, 18, 683-696.
    
    
18. Esposito, E.X.; Baran, K.; Kelly, K.; Madura, J.D
    Docking of sulfonamides to carbonic anhydrase II and IV.
    J. Molec. Graph. and Mod., 2000, 18, 283-289.
    
    
19. Esposito, E.X.; Baran, K.; Kelly, K.; Madura, J.D
    Docking substrates to metalloenzymes.
    Molecular Simulation, 2000, 24, 293-306.
    
    
20. Feher, M.; Schmidt, J.M.
    Property distributions: Differences between drugs, natural products, and molecules from combinatorial chemistry, J. Chem. Inf. Comput. Sci., 2003, 43, 218-227.
    
    
21. Feher, M.; Schmidt, J.
    Metric and multidimensional scaling: Efficient tools for clustering molecular conformations,
    J. Chem. Inf. Comput. Sci., 2001, 41, 346-353.
    
    
22. Feher, M.; Schmidt, J.M.
    Multiple flexible alignment with SEAL: A study of molecules acting on the colchicine binding site,
    J. Chem. Inf. Comput Sci. , 2000, 40, 495-502.
    
    
23. Feher, M.; Sourial, E.; Schmidt, J.M.
    A simple model for the prediction of blood-brain partitioning. Int. J. Pharmaceutics, 2000, 201, 239-247.
    
    
24. Fukiage, C.; Nakajima, E.; Ma, H.; Azuma, M.; Shearer, T.R.
    Charaterization and regulation of lens-specific calpain Lp82, J. Biol. Chem., 2002, 277, 20678-20685.
    
    
25. Gagnon, L.; DiMarco, M.; Kirby, R.; Zacharie, B.; Penney, C.L.
    D-LysAsnProTyr tetrapeptide: a novel B-cell stimulant and stabilized bursin mimetic, Vaccine, 2000, 18, 1886-1892.
    
    
26. Gao, H.
    Application of BCUT metrics and genetic algorithm in binary QSAR analysis,
    J. Chem. Inf. Comput. Sci., 2001, 41, 402-407.
    
    
27. Gao, H.; Williams, C.; Labute, P; Bajorath, J.
    Binary quantitative structure - activity relationship (QSAR) analysis of estrogen receptor ligands.
    J. Chem. Inf. Comput. Sci., 1999, 39, 164-168.
    
    
28. 「基礎と実習　バイオインフォマティクス」
    郷通子、高橋健一　編、
    2004, 共立出版（株）
    
    
29. Godden, J.W.; Furr, J.R.; Bajorath, J.
    Recursive median partitioning for virtual screening of large databases, J. Chem. Inf. Comput. Sci., 2003, 43, 182-188.
    
    
30. Godden, J.W.; Bajorath, J.
    Chemical Descriptors with Distinct Levels of Information Content and Varying Sensitivity to Differences between Selected Compound Databases Identified by SE-DSE Analysis,
    J. Chem. Inf. Comput. Sci., 2002, 42, 87-93.
    
    
31. Godden, J.W.; Xue, L.; Kitchen, D.B.; Stahura, F.L.; Schermerhorn, E.J.; Bajorath, J.
    Median partitioning. A novel method for the selection of representative subsets from large compound pools, J. Chem. Inf. Comput. Sci. , 2002, 42, 885-893.
    
    
32. Godden, J.W.; Stahura, F.L.; Bajorath, J.
    Variability of molecular descriptors in compound databases revealed by shannon entropy calculations,
    J. Chem. Inf. Comput. Sci., 2000, 40, 796-800.
    
    
33. Godden, J.W.; Xue, L.; Bajorath, J.
    Combinatorial preferences affect molecular similarity/diversity calculations using binary fingerprint and Tanimoto coefficients,
    J. Chem. Inf. Comput. Sci., 2000, 40, 163-166.
    
    
34. Goto, J.; Kataoka, R.; Hirayama, N.
    Ph4Dock: Pharmacophore-Based Protein-Ligand Docking. J. Med. Chem., 2004, 47, 6804-6811.
    
    
35. Goto, J.; Kataoka, R.; Muta H.; Hirayama, N.
    ASEDock-Docking Based on Alpha Spheres and Excluded Volumes. J. Chem. Inf. Model., 2008, 48, 583-590.
    
    
36. Giuliano, B.; Clayton, S.; Nigel, J., W.; Franco, L.
    In Silico Prediction of Volume of Distribution in Human Using Linear and Nonlinear Models on a 669 Compound Data Set. J. Med. Chem., 2009, 52, 4488-4495.
    
    
37. Hamada T, Kawashima M, Watanabe H, Tagami J, Senpuku H.
    Molecular interactions of surface protein peptides of Streptococcus gordonii with human salivary components. Infect. Immun. 2004, 72(8), 4819-26.
    
    
38. Hasegawa, K.; Koyama, M.; Funatsu, K.
    Quantitative Prediction of Regioselectivity Toward Cytochrome P450/3A4 Using Machine Learning Approaches. Mol. Inf. 2010, 29, 243-249.
    
    
39. Hasegawa, K.; Funatsu, K.
    Advanced PLS Technique Focusing on Visualization and Chemical Interpretation - SOMPLS Analysis of Serine Protease Inhibitors -. J. Comput. Aided. Chem., 2010, 11, 56-61.
    
    
40. Hidaka, K.; Kimura, T.; Abdel-Rahman, H., M.; Nguyen, J.-T.; McDaniel, K., F.; Kohlbrenner, W., E.; Katsuki, N.; Tanaka, Y.; Matsumoto, H.; Wang, J.; Hayashi, Y.; Kempf, D., J.; Kiso, Y.
    Small-Sized Human Immunodeficiency Virus Type-1 Protease Inhibitors Containing Allophenylnorstatine to Explore the S₂' Pocket. J. Med. Chem., 2009, 52, 7604-7617.
    
    
41. Howarth, N.M.; Purohit, A.; Robinson, J.J.; Vicker, N.; Reed, M.J.; Potter, B.V.L.
    Estrone 3-sulfate mimics, inhibitors of estrone sulfatase activity: Homology model construction and docking studies, Biochemistry, 2002, 41, 14801-14814.
    
    
42. Huang, J.; Hamasaki, T.; Ozoe, F.; Ohta, H.; Enomoto, K.; Kataoka, H.; Sawa Y.; Hirota, A.; Ozoe, Y.
    Identification of Critical Structural Determinants Responsible for Octopamine Binding to the R-Adrenergic-like Bombyx mori Octopamine Receptor. Biochemistry, 2007, 46, 5896-5903.
    
    
43. Ishii, K.; Kondo, K.; Takahashi, M.; Kimura M.; Endoh, M.
    An amino acid residue whose change by mutation affects drug binding to the HERG channel,
    FEBS Letters, 2001, 506, 191-195.
    
    
44. Ito, S.; Nakahari, T.; Yamamoto, D.
    The structural feature surrounding glycated lysine residues in human hemoglobin,
    Biomed. Res., 2011, 32. 217-223. [NEW]


45. Ito, S.; Nakahari, T.; Yamamoto, D.
    Relationship between impaired glycation and the N-terminal structure of the Hb G\örwihl [$5 (A2) Pro->Ala] variant,
    Hemoglobin, 2010, 34. 151-156. [NEW]


46. Ito, S.; Yamamoto, D.
    Identification of two bromocresol purple binding sites on human serum albumin,
    Clin. Chim. Acta, 2010, 411. 1536-1538. [NEW]


47. 片岡良一、後藤純一
    「バイオインフォマティクスと創薬」
    ポストシークエンスタンパク質実験法 1ー全タンパク質の解析ー
    大島泰郎、鈴木紘一、藤井義明、村松喬　編、
    p191-201、 2002,（株）東京化学同人
    
    
48. 片岡良一、後藤純一
    ASEDock―結合部位の形状に基づくドッキング
    Molecular Science, 2008, 2, NP008.
    
    
49. Katada, S.; Hirokawa, T.; Oka, Y.; Suwa, M.; Touhara, K.
    Structural Basis for a Broad But Selective Ligand Spectrum of a Mouse Olfactory Receptor: Mapping the Odorant-Binding Site,
    J. Neurosci., 2005, 25, 1806-1815.
    
    
50. Kinomoto, M.: Yokoyama, M.: Sato, H.: Kojima, A.: Kurata, T.: Ikuta, K.: Sata, T.: Tokunaga, K.
    Amino Acid 36 in the Human Immunodeficiency Virus Type 1 gp41 Ectodomain Controls Fusogenic Activity: Implications for the Molecular Mechanism of Viral Escape from a Fusion Inhibitor,
    J. Virol., 2005, 79, 5996-6004.
    
    
51. Kinomoto, M.: Appiah-Opong, R.: Brandful, J.A.M..: Yokoyama, M.: Nii-Trebi, N.: Ugly-Kwame, E.: Sato, H.: Ofori-Adjei, D.: Kurata, T.: Barre-Sinoussi, F.O.: Sata, T.: Tokunaga, K.
    HIV-1 proteases from drug-na ve West African patients are differentially less susceptible to protease inhibitors,
    Clin. Infect. Dis., 2005, 41, 243-251.
    
    
52. Kiso, A.: Hidaka, K.: Kimura, T.: Hayashi, Y.: Nezami, A.: Freire, E.: Kiso, Y.
    Search for substrate-based inhibitors fitting the S2' space of malarial aspartic protease plaasmepsin II,
    J. Peptide Sci., 2004, 10, 641-647.
    
    
53. Kotake, T.: Hayashi, Y.: Rajesh, S.: Mukai, Y.: Takiguchi, Y.: Kimura, T.: Kiso, Y.
    Design and synthesis of a new polymer-supported Evans-type oxazolidinone: an efficient chiral auxiliary in the solid-phase asymmetric alkylation reaction,
    Tetrahedron, 2005, 61, 3819-3833.
    
    
54. Kubo, Y.; Yokoyama, M.; Yoshii, H.; Mitani, C.; Tominaga, C.; Tanaka, Y.; Sato, H.; Yamamoto, N.
    Inhibitory role of CXCR4 glycan in CD4-independent X4-tropic human immunodeficiency virus type 1 infection and its abrogation in CD4-dependent infection,
    J. Gen. Virol., 2007, 88, 3139-3144.
    
    
55. Kurotsuchi A.; Murakumo Y.; Jijiwa M.; Kurokawa K.; Itoh Y.; Kodama Y.; Kato T.; Enomoto A.; Asai N.; Terasaki H.; Takahashi M.
    Analysis of DOK-6 function in downstream signaling of RET in human neuroblastoma cells,
    Cancer Sci., 2010, 101, 1147-1155.
    
    
56. Labute, P.; Nilar, S.; Williams, C.
    A Probabilistic Approach to High Throughput Drug Discovery,
    Combinatorial Chemistry & High Throughput Screening, 2002, 5, 135-145.
    
    
57. Labute, P.; Williams, C.; Feher, M.; Sourial, E.; Schmidt, J.M.
    Flexible alignment of small molecules,
    J. Med. Chem., 2001, 44, 1483-1490.
    
    
58. Labute, P.
    A widely applicable set of descriptors,
    J. Mol. Graphics Mod. , 2000, 18, 464-477.
    
    
59. Li, X.; Baudry, J; Berenbaum, M.R.; Schuler, M.A.
    Structural and functional evolution of insect CYP6B proteins: from specialist to generalist P450,
    Proc. Natl. Acad. Sci. , 2004, 101, 2939-2944.
    
    
60. Lindstrom, A.; Pettersson, F; Almqvist, F; Berglund, A.; Kihlberg, J.; Linusson, A..
    Hierarchical PLS Modeling for Predicting the Binding of a Comprehensive Set of Structurally Diverse Protein-Ligand Complexes,
    J. Chem. Inf. Model. , 2006, 46, 1154-1167.
    
    
61. Manavalan, B.; Murugapiran, S.K.; Lee, G.; Choi, S.
    Molecular modeling of the reductase domain to elucidate the reaction mechanism of reduction of peptidyl thioester into its corresponding alcohol in non-ribosomal peptide synthetases.
    BMC Struct. Biol., 2010, 10:1.[NEW]
    
    
62. Meagher, K. L.; Lerner, M. G.; Carlson, H. A.
    Refining the Multiple Protein Structure Pharmacophore Method: Consistency across Three Independent HIV-1 Protease Models,
    J. Med. Chem., 2006, 49, 3478-3484.
    
    
63. Misumi, S.; Endo, M.; Mukai, R.; Tachibana K.;Umeda M.; Honda, T.,Takamune, N.; Shoji, S.
    A Novel Cyclic Peptide Immunization Strategy for Preventing HIV-1/AIDS Infection and Progression,
    J. Biol. Chem. , 2003, 278, 32335-32343.
    
    
    
64. Motomura, K.; Oka, T.; Yokoyama, M.; Nakamura, H.;Mori, H.; Ode, H.; Hansman, GS.; Katayama, K.; Kanda, T.; Tanaka, T.; Takeda, N.; Sato, H..
    the Norovirus Surveillance Group of Japan: Identification of Monomorphic and Divergent Haplotypes in 2006/2007 Norovirus GII/4 Epidemic Population by Genome-wide Tracing of Evolutionary History,
    J. Virol., 2008, 82, 11247-11262.
    
    
65. Murayama, N.; Imai, N.; Nakane, T.; Shimizu, M.;Yamazaki, H..
    Roles of CYP3A4 and CYP2C19 in methyl hydroxylated and N-oxidized metabolite formation from voriconazole, a new anti-fungal agent, in human liver microsomes,
    Biochem. Pharmacol. , 2007, 73, 2020-2026.
    
    
66. Nagata, N.; Iwata, N.; Hasegawa, H.; Fukushi, S.; Yokoyama, M.; Harashima, A.; Sato, Y.; Saijo, M.; Morikawa, S.; Sata, T.
    Participation of both host and virus factors in induction of severe acute respiratory syndrome in F344 rats infected with SARS coronavirus,
    J. Virol., 2007, 81, 1848-1857.
    
    
67. Naganawa, S.; Yokoyama, M.; Shiino, T.; Suzuki, T.; Ishigatsubo, Y.; Ueda, A.; Shirai, A.; Takeno, M.; Hayakawa, S.; Sato, S.; Tochikubo, O.; Kiyoura, S.; Sawada, K.; Ikegami, T.; Kanda, T.; Kitamura, K.; Sato, H..
    Net Positive Charge of HIV-1 CRF01_AE V3 Sequence Regulates Viral Sensitivity to Humoral Immunity,
    PLoS ONE, 2008, 3, e3206.
    この論文はインフォマティクス統合プラットフォーム「InforSense」も使用しています
    
    
68. Nayeem, A.; Sitkoff, D.; Krystek, S., Jr.
    A comparative study of available software for high-accuracy homology modeling: From sequence alignments to strucutural models,
    Protein Science., 2006, 15, 808-824.
    
    
69. Niwa, T.; Asaki, T.; Kimura, S..
    NS-187 (INNO-406), a Bcr-Abl/Lyn Dual Tyrosine Kinase Inhibitor,
    Analytical Chemistry Insights., 2007, 2, 93-106.
    
    
70. Ogola, H., J., O.; Kamiike, T.; Hashimoto, N.; Ashida H.; Ishikawa T.; Shibata H.; Sawa Y.
    Molecular characterization of a novel peroxidase from the cyanobacterium Anabaena sp. strain PCC 7120. Applied and Environmental Microbiology, 2009, 75, 7509-7518.
    
    
71. Oka, T.; Yamamoto, M.; Yokoyama, M.; Ogawa, S.; Hansman, G. S.; Katayama, K.; Miyashita, K.; Takagi, H.; Tohya, Y.; Sato, H.; Takeda, N.
    Highly conserved configuration of catalytic amino acid residues among calicivirus-encoded proteases,
    J. Virol., 2007, 81, 6798-6806.
    
    
72. Okamoto, M.; Takayama, K.; Shimizu, T.; Ishida, K.; Takahashi, O.; Furuya, T.
    Identification of Death-Associated Protein Kinases Inhibitors Using Structure-Based Virtual Screening,
    J. Med. Chem., 2009, 52, 7323-7327.
    
    
73. Okazaki, S.; Suzuki, A.; Komeda, H.; Yamaguchi, S.; Asano, Y.; Yamane, T..
    Crystal Structure and Functional Characterization of a D-Stereospecific Amino Acid Amidase from
    Ochrobactrum anthropi SV3, a New Member of the Penicillin-recognizing Proteins,
    J. Mol. Biol., 2007, 368, 79-91.
    
    
74. Okazaki, S.; Suzuki, A.; Mizushima, T.; Kawano, T.;Komeda, H.; Asano, Y.; Yamane, T..
    The Novel Structure of a Pyridoxal 5′-Phosphate-Dependent Fold-Type I Racemase,
    α-Amino-ε-caprolactam Racemase from Achromobacter obae,
    Biochemistry, 2009, 48, 941-950.
    
    
75. 大川原　正、岡本良成、大塚雅巳
    「薬剤耐性克服と創薬-イマチニブの耐性克服をどうするか」
    癌治療と宿主、 2005, vol.17 No.2, p63(157)-71(165)
    
    
76. Pan, L.; Wen, Z.; Baudry, J.; Berenbaum, M.R.; Schuler, M.A..
    Identification of Variable Amino Acids in the SRS1 Region of CYP6B1 Modulating Furanocoumarin Metabolism,
    Arch. Biochem. Biophys., 2004, 422, 31-41.
    
    
77. Rose, S.
    Statistical design and application to combinatorial chemistry,
    Drug Discovery Today, 2002, 7, 133-138.
    
    
78. Rupasinghe, S.; Baudry, J.; Schuler, M.A.;
    Common active site architecture and binding strategy of four phenylpropanoid P450s from Arabidopsis thaliana as revealed by molecular modeling,
    Protein Eng., 2003, 16, 721-731.
    
    
79. Song, H.; Nakayama, E. E.; Yokoyama, M.; Sato, H.; Levy, J. A.; Shioda, T.
    A single amino acid of the human immunodeficiency virus type 2 capsid affects its replication in the presence of cynomolgus monkey and human TRIM5as,
    J. Virol., 2007, 81, 7280-7285.
    
    
80. Sato, F.; Hojo, S.; Sun, H.
    On the Transferability of Force Field Parameters-With an ab Initio Force Field Developed For Sulfonamides,
    J. Phys. Chem. A , 2003, 107, 248-257.
    
    
81. Schefzick, S.; Bradley, M.
    Comparison of commercially available genetic algorithms: gas as variable selection tool,
    J. Comput. Aided. Mol. Des., 2004, 18, 511-521.
    
    
82. Shimada, T.; Murayama, N.; Tanaka, K.; Takenaka, S; Imai, Y.; Hopkins, N.E.; Foroozesh, M.K.; Alworth, W.L.; Yamazaki, H.; Guengerich, F.P.; Komori, M..
    Interaction of Polycyclic Aromatic Hydrocarbons with Human Cytochrome P450 1B1 in Inhibiting Catalytic Activity,
    Chem. Res. Toxicol., 2008, 21, 2313-2323.
    
    
83. Shirakawa, K.; Takaori-kondo, A.; Yokoyama, M.; Izumi, T; Matsui, M.; Io, K.; Sato, T.; Sato, H.; Uchiyama, T..
    Protein kinase A-mediated phosphorylation regulates the interaction between APOBEC3G and HIV-1 Vif,
    Nat. Struct. Mol. Biol., 2008, 15, 1184-1191.
    
    
84. Soderling, S.H.; Beavo, J.A.
    Regulation of cAMP and cGMP signaling: new phosphodiesterases and new functions, Current Opinion in Cell Biology, 2000, 12, 174-179.
    
    
85. Song, M.; Breneman, C.M.; Bi, J.; Sukumar, N.; Bennett, K.P.; Cramer, S.; Tugcu, N..
    Prediction of protein retention times in anion-exchange chromotography systems using support vector regression, J. Chem. Inf. Comput. Sci., 2002, 42, 1347-1357.
    
    
86. Takaoka, Y.; Ohta, M.; Takeuchi, A.; Miura, K.; Matsuo, M.; Sakaeda, T.; Sugano, A.; Nishio, H..
    Ligand orientation governs conjugation capacity of UDP-glucuronosyltransferase 1A1,
    J. Biochem., 2010, 148, 25-28.
    
    Tanaka, T.; Okuda, T.; Yamamoto, Y..
    Characterization of the CYP3A4 Active Site by Homology Modeling,
    Chem. Pharm. Bull., 2004, 52, 830-835.
    
    
87. Tanaka, T.; Okuda, T.; Yamamoto, Y..
    Characterization of the CYP3A4 Active Site by Homology Modeling,
    Chem. Pharm. Bull., 2004, 52, 830-835.
    
    
88. Tanaka, T.; Kamiguchi, N.; Okuda, T.; Yamamoto, Y..
    Characterization of the CYP2C8 Active Site by Homology Modeling,
    Chem. Pharm. Bull., 2004, 52, 836-841.
    
    
89. Teramoto, T.; Sakakibara, Y.; Inada, K.; Kurogi, K.;Liu, M.; Suiko, M.; Kimura, M.;Kakuta, Y..
    Crystal structure of mSULT1D1, a mouse catecholamine sulfotransferase,
    FEBS Letters, 2008, 582, 3909-3914.
    
    
90. Ueno, Y.; Kato, T.; Sato, K.; Ito, Y.; Yoshida, M.; Inoue, T.; Shibata, A.; Ebihara, M.; Kitade, Y..
    Synthesis and Properties of Nucleic Acid Analogues Consisting of a Benzene-Phosphate Backbone
    J. Org. Chem., 2005, 70, 7925-7935.
    
    
91. Warr, W.
    Virtual high-throughput screening: Computational tools for drug discovery and design.
    Spectrum, Drug Discovery and Design, 2001, Issue 10, 1-16.
    
    
92. Whitling, J.M.; Spreitzer, G.; Wright, D.M.
    A combinatorial and informatics approach to CdS nanoclusters,  Advanced Materials, 2000, 12, 1377-1380.
    
    
93. Wildman, S.A.; Crippen, G.M.
    Prediction of physicochemical parameters by atomic coordinates,
    J. Chem. Inf. Comput. Sci., 1999, 39, 868-873.
    
    
94. Xue, L.; Stahura, F.L.; Godden, J.W.; Bajorath, J.
    Fingerprint scaling increases the probability of identifying molecules with similar activity in virtual screening calculations,
    J. Chem. Inf. Comput. Sci., 2001, 41, 746-53.
    
    
95. Xue, L.; Godden, J.W.; Gao, H; Bajorath, J.
    Mini-fingerprints detect similar activity of receptor ligands previously recognized only by three-dimensional pharmacophore-based methods,
    J. Chem. Inf. Comput. Sci., 2001, 41, 394-401.
    
    
96. Xue, L.; Bajorath, J.
    Molecular descriptors for effective classification of biologically active compounds based on principal component analysis identified by a genetic algorithm,
    J. Chem. Inf. Comput. Sci., 2000, 40, 801-809.
    
    
97. Xue, L.; Godden, J.W.; Bajorath, J.
    Database searching for compounds with similar biological activity using short binary bit string representations,
    J. Chem. Inf. Comput. Sci., 1999, 39, 881-886.
    
    
98. Xue, L.; Godden, J.W.; Gao, H; Bajorath, J.
    Identification of a preferred set of descriptors for compound classification based on principcal component analysis,
    J. Chem. Inf. Comput. Sci., 1999, 39, 669-704.
    
    
99. Yamamoto, Y.; Shuto, S.; Tamura, Y.; Kodama, T.; Hoshika, S.; Ichikawa, S.; Ueno, Y.; Ohtsuka, E.; Komatsu, Y.; Matsuda, A.
    Oligodeoxynucleotides Having a Loop Consisting of 3'-Deoxy-4'-C-(2-hydroxyethyl)thymidines Form Stable Hairpins.
    Biochemistry, 2004, 43, 1218-1227.
    
    
100. Yasri, A.; Hartsough, D.
     Toward an optimal procedure for variable selection and QSAR model building.
     J. Chem. Inf. Comput. Sci., 2001, 41, 8690-8699.
     
     
101. Yoshida, K.; Niwa, T.
     Quantitative Structure-Activity Relationship Studies on Inhibition of HERG Potassium Channels.
     J. Chem. Inf. Model., 2006, 46, 1371-1378.

1. Anraku, K.; Inoue, T.; Sugimoto, K.; Kudo, K.; Okamoto, Y.; Morii, T.; Mori, Y.; Otsuka, M.
   Design and synthesis of biotinylated inositol 1,3,4,5-tetrakisphosphate targeting Grp1 pleckstrin homology domain,
   Bioorg. Med. Chem., 2011, 19. 6833 - 6841.


2. Azuma, M.; Kabe, Y.; Kuramori, C.; Kondo, M.; Yamaguchi, Y.; Handa, H.
   Adenine Nucleotide Translocator Transports Haem Precursors into Mitochondria,
   PLoS ONE, 2008, 3. e3070.


3. Cen, X.; Nitta, A.; Ibi, D.; Zhao, Y.; Niwa, M.; Taguchi, K.; Hamada, M.; Ito, Y.; Ito, Y.; Wang, L.; Nabeshima, T.
   Identification of Piccolo as a regulator of behavioral plasticity and dopamine transporter internalization,
   Mol Psychiatry, 2008, 13. 451-463.


4. Chutiwitoonchai, N.; Hiyoshi, M.; Mwimanzi, P.; Ueno, T.; Adachi, A.; Ode, H.; Sato, H.; Fackler, O. T.; Okada, S.; Suzu, S.
   The Identification of a Small Molecule Compound That Reduces HIV-1 Nef-Mediated Viral Infectivity Enhancement,
   PLoS ONE, 2011, 6. e27696.


5. Daiyasu, H.; Hirokawa, T.; Kamiya, N.; Toh, H.
   Computational analysis of ligand recognition mechanisms by prostaglandin E₂ (subtype 2) and D₂ receptors,
   Theoretical Chemistry Accounts: Theory, Computation, and Modeling (Theoretica Chimica Acta), 2011, 130. 1131-1143.


6. Govindaraj, R. G.; Manavalan, B.; Lee, G.; Choi, S.
   Molecular Modeling-Based Evaluation of hTLR10 and Identification of Potential Ligands in Toll-Like Receptor Signaling,
   PLoS ONE, 2010, 5. e12713-.


7. Hakamata, W.; Ishikawa, R.; Ushijima, Y.; Tsukagoshi, T.; Tamura, S.; Hirano, T.; Nishio, T.
   Virtual ligand screening of ﾎｱ-glucosidase: Identification of a novel potent noncarbohydrate mimetic inhibitor,
   Bioorg. Med. Chem. Lett., 2012, 22. 62 - 64.


8. Hirakawa, H.; Akita, H.; Fujiwara, T.; Sugai, M.; Kuhara, S.
   Structural insight into the binding mode between the targeting domain of ALE-1 (92AA) and pentaglycine of peptidoglycan,
   Protein Engineering, Design and Selection, 2009, 22. 385-391.


9. Hou, D.-X.; Kumamoto, T.
   Flavonoids as Protein Kinase Inhibitors for Cancer Chemoprevention: Direct Binding and Molecular Modeling,
   Antioxid. Redox Signaling, 2010, 13. 691-719.


10. Huang, J.; Hamasaki, T.; Ozoe, F.; Ozoe, Y.
    Single amino acid of an octopamine receptor as a molecular switch for distinct G protein couplings,
    Biochem. Biophys. Res. Commun., 2008, 371. 610-614.


11. Iijima, S.; Lee, Y.-J.; Ode, H.; Arold, S.; Kimura, N.; Yokoyama, M.; Sato, H.; Tanaka, Y.; Strebel, K.; Akari, H.
    A non-canonical mu-1A-binding motif in the N-terminus of HIV-1 Nef determines its activity to down-regulate MHC-I in T lymphocytes,
    J. Virol., 2012, . .


12. Indarte, M.; Madura, J. D.; Surratt, C. K.
    Dopamine transporter comparative molecular modeling and binding site prediction using the LeuT_Aa leucine transporter as a template,
    Proteins: Struct., Funct., Bioinf., 2008, 70. 1033-1046.


13. Iwai, Y.; Murakami, K.; Gomi, Y.; Hashimoto, T.; Asakawa, Y.; Okuno, Y.; Ishikawa, T.; Hatakeyama, D.; Echigo, N.; Kuzuhara, T.
    Anti-Influenza Activity of Marchantins, Macrocyclic Bisbibenzyls Contained in Liverworts,
    PLoS ONE, 2011, 6. e19825.


14. Iwaki, T.; Shiota, K.; Al-Taweel, K.; Kobayashi, D.; Kobayashi, A.; Suzuki, K.; Yui, T.; Wadano, A.
    Inhibition of RuBisCO cloned from Thermosynechococcus vulcanus and expressed in Escherichia coli with compounds predicted by Molecular Operation Environment (MOE),
    J. Biosci. Bioeng., 2008, 105. 26 - 33.


15. Izuhara, Y.; Yamaoka, N.; Kodama, H.; Dan, T.; Takizawa, S.; Hirayama, N.; Meguro, K.; van Ypersele de Strihou, C.; Miyata, T.
    A novel inhibitor of plasminogen activator inhibitor-1 provides antithrombotic benefits devoid of bleeding effect in nonhuman primates,
    J Cereb Blood Flow Metab, 2010, 30. 904-912.


16. Kimura, T.; Hamada, Y.; Stochaj, M.; Ikari, H.; Nagamine, A.; Abdel-Rahman, H.; Igawa, N.; Hidaka, K.; Nguyen, J.-T.; Saito, K.; Hayashi, Y.; Kiso, Y.
    Design and synthesis of potent [beta]-secretase (BACE1) inhibitors with carboxylic acid bioisosteres,
    David W. Robertson Memorial Issue, Bioorg. Med. Chem. Lett., 2006, 16. 2380-2386.


17. Kumamoto, T.; Fujii, M.; Hou, D.-X.
    Akt is a direct target for myricetin to inhibit cell transformation,
    Mol. Cell. Biochem., 2009, 332. 33-41.


18. Manavalan, B.; Murugapiran, S.; Lee, G.; Choi, S.
    Molecular modeling of the reductase domain to elucidate the reaction mechanism of reduction of peptidyl thioester into its corresponding alcohol in non-ribosomal peptide synthetases,
    BMC Structural Biology, 2010, 10. 1.


19. Masada, S.; Terasaka, K.; Oguchi, Y.; Okazaki, S.; Mizushima, T.; Mizukami, H.
    Functional and Structural Characterization of a Flavonoid Glucoside 1,6-Glucosyltransferase from Catharanthus roseus,
    Plant Cell Physiol., 2009, 50. 1401-1415.


20. Murayama, N.; Imai, N.; Nakane, T.; Shimizu, M.; Yamazaki, H.
    Roles of CYP3A4 and CYP2C19 in methyl hydroxylated and N-oxidized metabolite formation from voriconazole, a new anti-fungal agent, in human liver microsomes,
    Biochem. Pharmacol., 2007, 73. 2020 - 2026.


21. Ogola, H. J. O.; Kamiike, T.; Hashimoto, N.; Ashida, H.; Ishikawa, T.; Shibata, H.; Sawa, Y.
    Molecular Characterization of a Novel Peroxidase from the Cyanobacterium Anabaena sp. Strain PCC 7120,
    Appl. Environ. Microbiol., 2009, 75. 7509-7518.


22. Okai, M.; Kubota, K.; Fukuda, M.; Nagata, Y.; Nagata, K.; Tanokura, M.
    Crystal Structure of [gamma]-Hexachlorocyclohexane Dehydrochlorinase LinA from Sphingobium japonicum UT26,
    J. Mol. Biol., 2010, 403. 260 - 269.


23. Okamoto, S.; Yu, F.; Harada, H.; Okajima, T.; Hattan, J.-i.; Misawa, N.; Utsumi, R.
    A short-chain dehydrogenase involved in terpene metabolism from Zingiber zerumbet,
    FEBS Journal, 2011, 278. 2892-2900.


24. Ordonez, P.; Hamasaki, T.; Isono, Y.; Sakakibara, N.; Ikejiri, M.; Maruyama, T.; Baba, M.
    Anti-human immunodeficiency virus type 1 activity of novel 6-substituted 1-benzyl-3-(3,5-dimethylbenzyl)uracil derivatives,
    Antimicrob. Agents Chemother., 2012, . .


25. Sakashita, H.; Akahoshi, F.; Yoshida, T.; Kitajima, H.; Hayashi, Y.; Ishii, S.; Takashina, Y.; Tsutsumiuchi, R.; Ono, S.
    Lead optimization of [(S)-[gamma]-(arylamino)prolyl]thiazolidine focused on [gamma]-substituent: Indoline compounds as potent DPP-IV inhibitors,
    Bioorg. Med. Chem., 2007, 15. 641-655.


26. Sassa, A.; Niimi, N.; Fujimoto, H.; Katafuchi, A.; Grﾃｺz, P.; Yasui, M.; Gupta, R. C.; Johnson, F.; Ohta, T.; Nohmi, T.
    Phenylalanine 171 is a molecular brake for translesion synthesis across benzo[a]pyrene-guanine adducts by human DNA polymerase kappa,
    Mutation Research/Genetic Toxicology and Environmental Mutagenesis, 2011, 718. 10 - 17.


27. Seto, T.; Ozaki, M.; Nosaka, S.
    Molecular Docking of Barbital Enantiomers to the Nicotinic Acetylcholine Receptor:Implications for the Mechanism of Anesthesia,
    CBIJ, 2012, 12. 14-24.


28. Suhara, Y.; Watanabe, M.; Motoyoshi, S.; Nakagawa, K.; Wada, A.; Takeda, K.; Takahashi, K.; Tokiwa, H.; Okano, T.
    Synthesis of New Vitamin K Analogues as Steroid and Xenobiotic Receptor (SXR) Agonists: Insights into the Biological Role of the Side Chain Part of Vitamin K,
    J. Med. Chem., 2011, 54. 4918-4922.


29. Suhara, Y.; Watanabe, M.; Nakagawa, K.; Wada, A.; Ito, Y.; Takeda, K.; Takahashi, K.; Okano, T.
    Synthesis of Novel Vitamin K₂ Analogues with Modification at the [omega]-Terminal Position and Their Biological Evaluation as Potent Steroid and Xenobiotic Receptor (SXR) Agonists,
    J. Med. Chem., 2011, 54. 4269-4273.


30. Tatara, Y.; Lin, Y.-C.; Bamba, Y.; Mori, T.; Uchida, T.
    Dipentamethylene thiuram monosulfide is a novel inhibitor of Pin1,
    Biochem. Biophys. Res. Commun., 2009, 384. 394-398.


31. Watanabe, Y.; Ibrahim, M. S.; Ellakany, H. F.; Kawashita, N.; Mizuike, R.; Hiramatsu, H.; Sriwilaijaroen, N.; Takagi, T.; Suzuki, Y.; Ikuta, K.
    Acquisition of Human-Type Receptor Binding Specificity by New H5N1 Influenza Virus Sublineages during Their Emergence in Birds in Egypt,
    PLoS Pathog, 2011, 7. e1002068.


32. Xue, Y.-L.; Miyakawa, T.; Hayashi, Y.; Okamoto, K.; Hu, F.; Mitani, N.; Furihata, K.; Sawano, Y.; Tanokura, M.
    Isolation and Tyrosinase Inhibitory Effects of Polyphenols from the Leaves of Persimmon, Diospyros kaki,
    J. Agric. Food Chem., 2011, 59. 6011-6017.


33. Yamaguchi, H.; Akitaya, T.; Yu, T.; Kidachi, Y.; Kamiie, K.; Noshita, T.; Umetsu, H.; Ryoyama, K.
    Molecular docking and structural analysis of cofactor-protein interaction between NAD<sup>+</sup> and 11ﾎｲ-hydroxysteroid dehydrogenase type 2,
    J. Mol. Model., 2011, . 1-12.


34. Yamaguchi, H.; Yu, T.; Kidachi, Y.; Akitaya, T.; Yoshida, K.; Kamiie, K.; Noshita, T.; Umetsu, H.; Ryoyama, K.
    Selective toxicity of glycyrrhetinic acid against tumorigenic r/m HM-SFME-1 cells is potentially attributed to downregulation of glutathione,
    Biochimie, 2011, 93. 1172 - 1178.


35. Yamaguchi, H.; Yu, T.; Noshita, T.; Kidachi, Y.; Kamiie, K.; Yoshida, K.; Akitaya, T.; Umetsu, H.; Ryoyama, K.
    Ligand-receptor Interaction between Triterpenoids and the 11beta-Hydroxysteroid dehydrogenase type 2 (11beta HSD2) Enzyme Predicts Their Toxic Effects against Tumorigenic r/m HM-SFME-1 Cells,
    J. Biol. Chem., 2011, 286. 36888-36897.


36. Yamakawa, N.; Suemasu, S.; Matoyama, M.; ichiro Tanaka, K.; Katsu, T.; Miyata, K.; Okamoto, Y.; Otsuka, M.; Mizushima, T.
    Synthesis and biological evaluation of loxoprofen derivatives,
    Bioorganic & Medicinal Chemistry, 2011, 19. 3299 - 3311.


37. Yokoyama, M.; Mori, H.; Sato, H.
    Allosteric Regulation of HIV-1 Reverse Transcriptase by ATP for Nucleotide Selection,
    PLoS ONE, 2010, 5. e8867.


38. Yoshikane, Y.; Tamura, A.; Yokochi, N.; Ellouze, K.; Yamamura, E.; Mizunaga, H.; Fujimoto, N.; Sakamoto, K.; Sawa, Y.; Yagi, T.
    Engineering Mesorhizobium loti pyridoxamine-pyruvate aminotransferase for production of pyridoxamine with l-glutamate as an amino donor,
    J. Mol. Catal. B: Enzym., 2010, 67. 104-110.